1. NSDUH. Results from the 2017 National Survey on Drug Use and Health. vol. NSDUH Series H-53. Substance Abuse and Mental Health Services Administration; Rockville, MD; 2018.
2. Hughes A, Williams MR, Lipari RN, Van Horn S. State estimates of past year cocaine use among young adults: 2014 and 2015. Report TC. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2016.
3. Pierce RC, O’Brien CP, Kenny PJ, Vanderschuren LJ. Rational development of addiction pharmacotherapies: successes, failures, and prospects. Cold Spring Harb Perspect Med. 2012;2:a012880.
4. Graham DL, Erreger K, Galli A, Stanwood GD. GLP-1 analog attenuates cocaine reward. Mol Psychiatry. 2013;18:961–2.
5. Sorensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, et al. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiol Behav. 2015;149:262–8.